XML 28 R15.htm IDEA: XBRL DOCUMENT v3.7.0.1
STOCKHOLDERS’ EQUITY
 3 Months Ended
Mar. 31, 2017
Stockholders' Equity Note [Abstract]  
STOCKHOLDERS’ EQUITY
Note 9:
STOCKHOLDERS’ EQUITY
 
Reverse Stock Split
 
On September 16, 2016, the Company effected a one for twelve reverse stock-split of our issued and outstanding common stock and has retroactively adjusted our common shares outstanding, options and warrants amounts outstanding. The Company has presented its share data for and as of all periods presented on this basis. The par value was not adjusted as a result of the one for twelve reverse stock split. All prior period share transactions included in the Company’s stock transactions and balances have been retroactively restated.
 
2017 Common Stock Transactions
 
2017 Management Compensation
 
On March 9, 2017, the Company issued 12,761 shares of stock in relation to the discretionary 2016 bonus awarded to Dr. Glynn Wilson. The fair value of the common stock of $55,000 was recognized as stock-based compensation in general and administrative expenses. The issuance was based on the closing price or our common stock of $4.31 per share, on the day immediately preceding the date the 2016 bonus award was approved by the Board of Directors.
 
On March 9, 2017, the Company issued 5,220 shares of stock in relation to the discretionary 2016 bonus awarded to Dr. John Bonfiglio. The fair value of the common stock of $22,500 was recognized as stock-based compensation in general and administrative expenses. The issuance was based on the closing price or our common stock of $4.31 per share, on the day immediately preceding the date the 2016 bonus award was approved by the Board of Directors.
 
Consulting Arrangements
 
During the three months ended March 31, 2017, the Company issued 31,667 shares of common stock as part of consulting agreements. The fair value of the common stock of approximately $133,000 was recognized as stock-based compensation in general and administrative expenses.